BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 975 filers reported holding BAXTER INTL INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $341,458 | -82.4% | 10,208 | -77.6% | 0.06% | -84.7% |
| Q1 2024 | $1,945,012 | +34.2% | 45,508 | +21.4% | 0.42% | +13.2% |
| Q4 2023 | $1,449,518 | +328.3% | 37,494 | +349.4% | 0.37% | +236.4% |
| Q1 2023 | $338,433 | -38.9% | 8,344 | -3.3% | 0.11% | -60.3% |
| Q2 2022 | $554,000 | -49.7% | 8,631 | -37.0% | 0.28% | -60.0% |
| Q3 2021 | $1,101,000 | +58.0% | 13,693 | +58.1% | 0.69% | +9.3% |
| Q2 2021 | $697,000 | +184.5% | 8,659 | +198.7% | 0.63% | +43.4% |
| Q1 2021 | $245,000 | -64.0% | 2,899 | -67.2% | 0.44% | +49.3% |
| Q3 2018 | $680,000 | -30.6% | 8,826 | -41.4% | 0.30% | +24.4% |
| Q1 2018 | $980,000 | +4.9% | 15,067 | +4.3% | 0.24% | -12.8% |
| Q4 2017 | $934,000 | +86.1% | 14,446 | +80.6% | 0.27% | +92.3% |
| Q3 2017 | $502,000 | +112.7% | 8,000 | +105.1% | 0.14% | +73.2% |
| Q2 2017 | $236,000 | -57.4% | 3,900 | -68.8% | 0.08% | -71.8% |
| Q4 2016 | $554,000 | +10.6% | 12,500 | +2.5% | 0.29% | -13.1% |
| Q1 2016 | $501,000 | +84.9% | 12,200 | +71.8% | 0.34% | +59.5% |
| Q4 2015 | $271,000 | – | 7,100 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
| SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
| Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
| Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
| HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
| Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
| 13D Management LLC | 200,318 | $14,791,000 | 3.77% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
| Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |